ORIX to Invest in the Israeli Venture Investor OurCrowd

TOKYO, Japan - November 20, 2020 - ORIX Corporation (“ORIX”) announced today that a US$ 60 million investment to acquire an approximately 10-percent stake in the issued equity of OurCrowd International General Partner, LP (“OurCrowd”), the Israeli global venture investing platform. ORIX will acquire the stake via its European subsidiary ORIX Corporation Europe N.V. (“OCE”), through a third-party allocation of new shares. After receiving the necessary approval from regulatory authorities, it will complete the share acquisition by March 31, 2021, and become the second-largest shareholder in OurCrowd, following the company’s founder.

OurCrowd is a venture capital firm established in Israel in 2013. Israel is home to the largest number of start-up companies per capita in the world*¹; as such, it is one of the world’s leading venture investment markets, and attracts global attention from companies and investors. A strength of OurCrowd is investment in start-up tech companies that use AI and other advanced technologies, and its investments cover a variety of fields, including digital health, fintech, mobility, and agriculture in 11 countries worldwide in Europe, North America, and Asia. OurCrowd boasts the largest number of investments of any venture capital firm headquartered in Israel*².

OurCrowd invests its own capital in all its funds, and procures capital through an online equity crowdfunding model. It provides investors with access both to individual startups and to individual funds, and enables them to choose investment opportunities and investment amounts; for this reason, OurCrowd attracts a diverse range of investors, including institutional investors, family offices and wealthy individuals.

OurCrowd also establishes and operates thematic funds in digital health, mobility, and other fields, as well as next-generation development funds in partnership with the Israel Innovation Authority. At present, it has some 150 billion yen’s worth of funding commitments; and investments in 220 companies and 22 funds.

ORIX will contribute to the expansion of OurCrowd’s business by helping identify new investors and investment opportunities in Asia; at the same time, by leveraging the access OurCrowd has to outstanding start-up companies and taking advantage of its expertise in venture capital management, looking ahead ORIX intends to consider joint investments with OurCrowd into overseas start-ups.

Going forward, ORIX will continue to actively invest in growth fields, and thereby seek to expand its business in markets around the world.

*1 Innovation in Israel Situation Report (2019)
*2 According to PitchBook’s data

Contact Information:
ORIX Corporation
Corporate Planning Department
Tel: +81-3-3435-3121

About ORIX:
ORIX Corporation (TSE: 8591; NYSE: IX) is a financial services group which provides innovative products and services to its customers by constantly pursuing new businesses.
Established in 1964, from its start in the leasing business, ORIX has advanced into neighboring fields and at present has expanded into lending, investment, life insurance, banking, asset management, automobile related, real estate and environment and energy related businesses. Since entering Hong Kong in 1971, ORIX has spread its businesses globally by establishing locations in 37 countries and regions across the world.
Going forward, ORIX intends to utilize its strengths and expertise, which generate new value, to establish an independent ORIX business model that continues to evolve perpetually. In this way, ORIX will engage in business activities that instill vitality in its companies and workforce, and thereby contribute to society. For more details, please visit our website: https://www.orix.co.jp/grp/en/
(As of March 31, 2020)

Caution Concerning Forward Looking Statements:
These documents May contain forward-looking statements about expected future events and financial results that involve risks and uncertainties. Such statements are based on our current expectations and are subject to uncertainties and risks that could cause actual results that differ materially from those described in the forward-looking statements. Factors that could cause such a difference include, but are not limited to, those described under “Risk Factors” in the Company’s annual report on Form 20-F filed with the United States Securities and Exchange Commission and under “(4) Risk Factors” of the “1. Summary of Consolidated Financial Results” of the “Consolidated Financial Results April 1, 2019 – March 31, 2020.”